Ph2 Data

CCM_Ph2_Safety1

1. In the REC-400 mg arm these consisted of dizziness, rash, anemia, nausea and peripheral edema. In the placebo arm these consisted of dizziness and erythema multiforme. Across both arms, TEAEs related to study drug were Grade 1 or 2.

Format

JPEG

Source

Recursion Pharmaceuticals, Inc.

Téléchargements